Effect of zymosan-activated plasma on the deformability of rabbit polymorphonuclear leukocytes

H Inano1, D English, C M Doerschuk

  • 1University of British Columbia Pulmonary Research Laboratory, St. Paul's Hospital, Vancouver, Canada.

Insights

Zymosan-activated plasma (ZAP) causes rapid stiffening of polymorphonuclear leukocytes (PMN), impairing their ability to deform. This PMN stiffening, mediated by F-actin polymerization, contributes to neutropenia during inflammation.

Area of Science:

  • Immunology
  • Cell Biology
  • Hematology

Background:

  • Inflammatory mediators cause neutropenia via polymorphonuclear leukocyte (PMN) sequestration in microvasculature.
  • PMN sequestration may result from reduced deformability, hindering passage through capillaries.

Purpose of the Study:

  • To investigate if complement fragments in zymosan-activated plasma (ZAP) induce rapid PMN stiffening.
  • To elucidate the role of the cytoskeleton in ZAP-induced changes in PMN deformability.

Main Methods:

  • PMN deformability assessed by pressure filtration through 5-micron pores.
  • F-actin and microtubule assembly inhibition using cytochalasin B and colchicine, respectively.
  • In vivo studies evaluating PMN margination and sequestration.

Main Results:

  • ZAP treatment rapidly decreased PMN deformability.
  • Inhibition of F-actin formation enhanced PMN deformability and reduced ZAP-induced stiffening.
  • Microtubule inhibition did not affect normal or ZAP-induced PMN deformability.

Conclusions:

  • ZAP induces rapid PMN stiffening mediated by the cytoskeleton.
  • F-actin polymerization appears to be the primary mechanism behind ZAP-induced PMN deformability reduction.
  • These findings offer insights into inflammatory processes and neutropenia.

Related Concept Videos